| KPNA2 immunoreactivity | |||
---|---|---|---|---|
Variable | Case No. | Low (N = 101) | High (N = 75) | P * |
Sex | Â | Â | Â | 0.038 |
  Male | 78 | 48 | 30 |  |
  Female | 98 | 53 | 45 |  |
Age (y) | Â | Â | Â | 0.95 |
  ≥70 | 84 | 48 | 36 |  |
  <70 | 92 | 53 | 39 |  |
BMI (kg/m2) | Â | Â | Â | 0.26 |
  >27 | 37 | 24 | 13 |  |
  27-22 | 81 | 46 | 35 |  |
  <22 | 58 | 31 | 27 |  |
Tumor size (cm) | Â | Â | Â | 0.46 |
  ≥3.5 | 81 | 41 | 40 |  |
  <3.5 | 95 | 60 | 35 |  |
T stage | Â | Â | Â | <0.001 |
  Ta-T1 | 61 | 48 | 13 |  |
  T2 | 70 | 36 | 34 |  |
  T3 | 42 | 17 | 25 |  |
  T4 | 3 | 0 | 3 |  |
Pathologic lymph node stage | Â | Â | Â | 0.25 |
  N0 | 168 | 98 | 70 |  |
  N+ | 8 | 3 | 5 |  |
G grade | Â | Â | Â | <0.001 |
  G1 | 3 | 3 | 0 |  |
  G2 | 105 | 77 | 28 |  |
  G3 | 68 | 21 | 47 |  |
eGFR (ml/min/1.73Â m2)# | Â | Â | Â | 0.83 |
  ≥60 | 77 | 48 | 29 |  |
  60-15 | 90 | 49 | 41 |  |
  <15 | 9 | 4 | 5 |  |
Hydronephrosis | Â | Â | Â | 0.24 |
  Absent | 70 | 46 | 24 |  |
  Present | 106 | 65 | 41 |  |
Location | Â | Â | Â | 0.30 |
 | 81 | 50 | 31 |  |
  Renal pelvis Proximal | 6 | 5 | 1 |  |
  Middle | 17 | 9 | 8 |  |
  Distal ureter | 52 | 26 | 26 |  |
  Multiple | 20 | 11 | 9 |  |
Side | Â | Â | Â | 0.95 |
  Left | 82 | 49 | 33 |  |
  Right | 94 | 52 | 42 |  |
Tumor multiplicity | Â | Â | Â | 0.99 |
  Single tumor focus | 121 | 69 | 52 |  |
  Multiple tumor foci | 55 | 32 | 23 |  |
Tumor configuration | Â | Â | Â | 0.53 |
  Papillary | 140 | 82 | 58 |  |
  Nonpapillary | 36 | 19 | 17 |  |